Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial

The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis

(2021) Martin Ho et al.   Statistics in Biopharmaceutical Research

Bayesian semiparametric meta‐analytic‐predictive prior for historical control borrowing in clinical trials

(2021) Bradley Hupf et al.   STATISTICS IN MEDICINE

Predictively consistent prior effective sample sizes

(2020) Beat Neuenschwander et al.   BIOMETRICS

A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)

(2020) Mercedeh Ghadessi et al.   Orphanet Journal of Rare Diseases

Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets

(2020) Rhian Daniel et al.   BIOMETRICAL JOURNAL

Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls

(2019) Jiacheng Yuan et al.   Journal of Biopharmaceutical Statistics

Using simulation studies to evaluate statistical methods

(2019) Tim P. Morris et al.   STATISTICS IN MEDICINE

An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma

(2019) James Normington et al.   Contemporary Clinical Trials

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

(2018) Thomas Powles et al.   LANCET

Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials

(2018) Jessica Lim et al.   Therapeutic Innovation & Regulatory Science

1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

(2018) I Chau et al.   ANNALS OF ONCOLOGY

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

(2017) Arjun V Balar et al.   LANCET

Covariate-adjusted borrowing of historical control data in randomized clinical trials

(2017) Baoguang Han et al.   PHARMACEUTICAL STATISTICS

Matching on the Estimated Propensity Score

(2016) Alberto Abadie et al.   ECONOMETRICA

Studying noncollapsibility of the odds ratio with marginal structural and logistic regression models

(2016) Menglan Pang et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes

(2015) Peter C Austin et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Robust meta-analytic-predictive priors in clinical trials with historical control information

(2014) Heinz Schmidli et al.   BIOMETRICS

Use of historical control data for assessing treatment effects in clinical trials

(2013) Kert Viele et al.   PHARMACEUTICAL STATISTICS

Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials

(2011) Brian P. Hobbs et al.   BIOMETRICS

Summarizing historical information on controls in clinical trials

(2010) Beat Neuenschwander et al.   Clinical Trials

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

A weakly informative default prior distribution for logistic and other regression models

(2009) Andrew Gelman et al.   Annals of Applied Statistics

A note on the power prior

(2009) Beat Neuenschwander et al.   STATISTICS IN MEDICINE